TPT Overview

 

The Topical Products and Technology (TPT) Group has four commercialized products: Pennsaid®, Pennsaid 2%, the heated lidocaine/tetracaine patch (HLT Patch) and Pliaglis, a pipeline of products at various stages of development focusing on the following therapeutic areas: pain, dermatology, endocrinology and the central nervous system (CNS) and four topical and transdermal proprietary drug delivery (TTDD) platforms. The TTDD platforms are multiplexed molecular penetration enhancers (MMPE™), Controlled Heat-Assisted Drug Delivery (CHADD™), Peel and DuraPeel™.